Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study

Abstract Objectives To assess the efficacy and safety of preoperative neoadjuvant everolimus in renal angiomyolipomas (AML) patients with or without Tuberous Sclerosis Complex (TSC). Materials and Methods This multi‐institutional retrospective study enrolled renal AML patients who underwent partial...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ruopeng Su, Tingxuan Huang, Liangyou Gu, Yige Bao, Zhihong Liu, Pinghong Dao, Lin Yao, Xiaoyi Hu, Guanghou Fu, Jitao Wu, Thibault Tricard, Guangyu Wu, Minfeng Chen, Chancan Li, Zhiyang Huang, Bing Zheng, Yonghui Chen, Wei Xue, Gang Guo, Pei Dong, Jiwei Huang, Jin Zhang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2024-09-01
Saila:	Cancer Medicine
Gaiak:	adverse events everolimus neoadjuvant renal angiomyolipomas treatment response tuberous sclerosis complex
Sarrera elektronikoa:	https://doi.org/10.1002/cam4.70181
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!